비소세포 폐암의 병기 결정에서 F-18 FDG PET의 역할 (The Role of PET in Staging Non-Small Cell Lung Cancer) |
Author |
현인영, |
In Young Hyun, M.D. |
Affiliation |
. Departments of Nuclear Medicine, Inha University College of Medicine, Inchon, Korea |
Abstract |
Lung cancer has become a leading cause of cancer death in Korea. Accurate staging of non-small cell lung
cancer (NSCLC) is essential to the ability to offer a patient the most effective available treatment and the best
estimate of prognosis. PET with F-18 fluorodeoxyglucose (FDG) is indicated for the nodal staging of NSCLC and
detection of distant metastases. Use of PET for mediastinal staging should not be relied on as a sole staging
modality, and positive findings should be confirmed by mediastinoscopy. FDG PET avoids futile surgery by a more
accurate selection of patients, especially by the detection of unexpected distant metastases.(Korean J Nucl Med
38(6):481-485, 2004) |
Keyword |
F-18 fluorodeoxyglucose (FDG), non-small cell lung cancer (NSCLC), positron emission tomography (PET), |
Full text Article |
3806481.pdf
|
|
|